Navigation Links
Pig-induced pluripotent stem cells may be safer than previously thought
Date:12/9/2011

Athens, Ga. Pig stem cell research conducted by two animal scientists at the University of Georgia reveals a better way to determine the safety of future stem cell therapies than rodent-based models.

Rodent studies are likely inadequate for testing many human therapiesincluding pharmaceuticalssince 50 percent of all chemicals test positive as carcinogens in rodents regardless of their source or identity, according to Thomas Hartung, a professor in the Bloomsburg College of Public Health at Johns Hopkins University. He suggests these rodent studies may be no better than a coin toss. For example, some components in coffee appear to be carcinogenic in rodents, but in humans moderate coffee consumption may reduce the risk of cancer.

In 2010, UGA faculty Steve Stice and Franklin West introduced 13 pigs that have shown promise in unlocking the path to new therapies. The pigs recently produced another positive finding: These adult-cell-sourced stem cells don't form tumors in pigs.

"Pluripotent stem cells have significant potential for stem cell therapies," said West, an animal science researcher and assistant professor in the UGA College of Agricultural and Environmental Sciences. "However, tests in mice often resulted in tumor formation that frequently led to death."

The formation of tumors has raised concerns about the safety of induced pluripotent stem cells, or iPSCs, and cells derived from these stem cells. Until now, all iPSC safety studies have been performed in rodent models.

"To address the concern, our research team studied tumor formation in pigs generated from pig iPSCs," West said. "Brain, skin, liver, pancreas, stomach, intestine, lung, heart, kidney, muscle, spleen and gonad tissues from all 11 pigs tested showed no evidence of tumors."

The absence of tumor formation in these pigs suggests that iPSCs can safely incorporate into tissues without tumor formation.

"Being able to safely use iPSCs without the potential of causing tumors is essential for this promising stem cell therapy to become a viable treatment option," said Stice, a Georgia Research Alliance Eminent Scholar in the College of Agricultural and Environmental Sciences. "We now have graduate students working on making neural cells from the human and pig stem cells to help further the studies. The human stem cells were effective in a rodent model for stroke, but rodent studies are not rigorous enough to start human clinical trials."

West agrees. "Over 700 drug treatments have gone to human clinical trials for stroke alone based on findings in rodents and have turned out not to be viable in humans," he said. "The pigs are much more human like, and they are going to be a much better model to study strokes."

West is leading a cooperative project between the UGA Regenerative Bioscience Center and stroke researchers at Georgia Health Sciences University. "This project will improve the speed and efficiency of treatment development for stroke and many other conditions and potentially reduce the number of nonhuman primates used in research," he said.

Additionally, Stice and West have now bred the pigs produced from iPSCs and have proven the stem cells did pass to the offspring. This finding opens the door for better animal-sourced tissue for human regenerative medicine such as islet cells that produce insulin for diabetic patients.

Using iPSC technology, the UGA Regenerative Bioscience Center is working with researchers at Emory University to make pigs whose cells from the pancreas would demonstrate decreased rejection in human treatments.

"The next step would be to put these pig insulin-producing cells into other animals, potentially dogs or cats suffering from diabetesto see if it will produce insulin for them without being rejected," Stice said. "So, it's moving forward. Never as fast as we like, but it's moving."


'/>"/>

Contact: Franklin West
westf@uga.edu
706-542-0988
University of Georgia
Source:Eurekalert

Related medicine news :

1. Johns Hopkins researchers develop safer way to make induced pluripotent stem cells
2. NYSCF - Robertson investigator publishes research to better understand pluripotent stem cells
3. U of M researchers improve method to create induced pluripotent stem cells
4. UCLA stem cell researchers uncover mechanism that regulates human pluripotent stem cell metabolism
5. New Study Uses Adult Stem Cells in Effort to Save Limbs of Patients with Peripheral Arterial Disease
6. New study suggests stem cells sabotage their own DNA to produce new tissues
7. Attacking cancer cells with hydrogel nanoparticles
8. UCR researcher identifies mechanism malaria parasite uses to spread in red blood cells
9. Pittsburgh Neurosurgeons Explore Use of Drug that Illuminates Brain Tumor Cells To Guide Surgery
10. New tool illuminates connections between stem cells and cancer
11. Bitter melon extract attacks breast cancer cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... ... August 22, 2017 , ... “Wilderness Voices”: a collection of ... “Wilderness Voices” is the creation of published author, Martha McKown, an ordained United ... inspired as a very young child when her older sisters studied High School literature. ...
(Date:8/22/2017)... ... August 22, 2017 , ... “Covert Awakening”: Walid’s ... of published author, Julianne Hale, a consultant for the Intelligence Community. For ... focusing on the Near East region. Julianne has written hundreds of reports ...
(Date:8/22/2017)... , ... August 22, 2017 , ... ... Stewart is the Founder and Managing Member for t4 Leadership Development & Consulting. ... critical to his definition of “success”: physician leadership development, servant leadership, data driven ...
(Date:8/22/2017)... ... ... “Call Of Spiritual Duty”: a revelation in an era defined by intentional ... Growing up on the streets of North Visalia, California, Carlos Lizarde quickly became familiar ... keys to his life, he noticed immediately that opportunities and blessings began to shift ...
(Date:8/21/2017)... ... August 22, 2017 , ... PracticeMatch, a company that ... healthcare employers connect with physicians and advanced practitioners like nurse practitioners and ... in August through November of this year. The online career fairs will allow ...
Breaking Medicine News(10 mins):
(Date:7/31/2017)... , July 31, 2017 Three Tru-D SmartUVC ... South Korea . Tru-D, short for "Total Room Ultraviolet ... operating rooms after an environmental services (ES) professional cleans the area with ... ... "Although the BAACH ...
(Date:7/27/2017)... 27, 2017  Zimmer Biomet Holdings, Inc. (NYSE and ... June 30, 2017.  The Company reported second quarter net ... the prior year period, and an increase of 2.1% ... points of contribution from the LDR Holding Corporation acquisition, ... quarter of 2016, or 0.3% on a constant currency ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: